Alternatives to OncoDecipher

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Biotechnology company developing novel therapies for multiple myeloma.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered insights platform for life sciences and biotech workflows.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Compressing biology to develop the next generation of therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Digital pathology imaging technology and AI-driven precision pathology software.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Develops a computational model of the human body for drug discovery and development.

Synthetic biology startup optimizing gene expression for food and biotech applications.

A global oncology company developing and commercializing innovative cancer treatments.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

EU-based company providing personalized medicine solutions for medical practitioners.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered spatial biology platform for precision medicine and drug development.

Developing engineered biologics to harness the immune system for disease treatment.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.